|
Originally published In Press as doi:10.1074/jbc.M407834200 on August 4, 2004
J. Biol. Chem., Vol. 279, Issue 41, 42605-42611, October 8, 2004
Lysosomal Phospholipase A2 Is Selectively Expressed in Alveolar Macrophages*
Akira Abe ,
Miki Hiraoka ,
Susan Wild ,
Steven E. Wilcoxen ,
Robert Paine, III , and
James A. Shayman ¶
From the
Division of Nephrology and Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan 48109
Lung surfactant is the surface-active agent comprised of phospholipids and proteins that lines pulmonary alveoli. Surfactant stabilizes the alveolar volume by reducing surface tension. Previously, we identified a lysosomal phospholipase A2, termed LPLA2, with specificity toward phosphatidylcholine and phosphatidylethanolamine. The phospholipase is localized to lysosomes, is calcium-independent, has an acidic pH optimum, and transacylates ceramide. Here, we demonstrate that LPLA2 is selectively expressed in alveolar macrophages but not in peritoneal macrophages, peripheral blood monocytes, or other tissues. Other macrophage-associated phospholipase A2s do not show a comparable distribution. LPLA2 is of high specific activity and recognizes disaturated phosphatidylcholine as a substrate. The lysosomal phospholipase A2 activity is six times lower in alveolar macrophages from mice with a targeted deletion of the granulocyte macrophage colony-stimulating factor (GM-CSF), a model of impaired surfactant catabolism, compared with those from wild-type mice. However, LPLA2 activity and protein levels are measured in GM-CSF null mice in which GM-CSF is expressed as a transgene under the control of the surfactant protein C promoter. Thus LPLA2 may be a major enzyme of pulmonary surfactant phospholipid degradation by alveolar macrophages and may be deficient in disorders of surfactant metabolism.
Received for publication, July 12, 2004
, and in revised form, August 4, 2004.
* This work is supported by grants from the Michigan Economic Development Corporation Life Sciences Corridor Fund (to J. A. S.), National Institutes of Health Grants RO1 DK55823 (to J. A. S.) and HL64558 (to R. P.), and a Veterans Administration Merit Review (to R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY490816.
¶ To whom correspondence should be addressed: Nephrology Division, Dept. of Internal Medicine, University of Michigan, Box 0676, Rm. 1560 MSRBII, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-0676. Tel.: 734-763-0992; Fax: 734-763-0982; E-mail: jshayman{at}umich.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Abe, R. Kelly, J. Kollmeyer, M. Hiraoka, Y. Lu, and J. A. Shayman
The Secretion and Uptake of Lysosomal Phospholipase A2 by Alveolar Macrophages
J. Immunol.,
December 1, 2008;
181(11):
7873 - 7881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Hurley and B. A. McCormick
Multiple Roles of Phospholipase A2 during Lung Infection and Inflammation
Infect. Immun.,
June 1, 2008;
76(6):
2259 - 2272.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Thomassen, B. P. Barna, A. G. Malur, T. L. Bonfield, C. F. Farver, A. Malur, H. Dalrymple, M. S. Kavuru, and M. Febbraio
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis
J. Lipid Res.,
December 1, 2007;
48(12):
2762 - 2768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Abe, M. Hiraoka, and J. A. Shayman
The acylation of lipophilic alcohols by lysosomal phospholipase A2
J. Lipid Res.,
October 1, 2007;
48(10):
2255 - 2263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Andreeva, M. A. Kutuzov, and T. A. Voyno-Yasenetskaya
Regulation of surfactant secretion in alveolar type II cells
Am J Physiol Lung Cell Mol Physiol,
August 1, 2007;
293(2):
L259 - L271.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zhao, L. G. Fernandez, A. Doctor, A. K. Sharma, A. Zarbock, C. G. Tribble, I. L. Kron, and V. E. Laubach
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury
Am J Physiol Lung Cell Mol Physiol,
November 1, 2006;
291(5):
L1018 - L1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Abe, M. Hiraoka, and J. A. Shayman
Positional specificity of lysosomal phospholipase A2
J. Lipid Res.,
October 1, 2006;
47(10):
2268 - 2279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hiraoka, A. Abe, Y. Lu, K. Yang, X. Han, R. W. Gross, and J. A. Shayman
Lysosomal phospholipase A2 and phospholipidosis.
Mol. Cell. Biol.,
August 1, 2006;
26(16):
6139 - 6148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hiraoka, A. Abe, and J. A. Shayman
Structure and function of lysosomal phospholipase A2: identification of the catalytic triad and the role of cysteine residues
J. Lipid Res.,
November 1, 2005;
46(11):
2441 - 2447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Brant and R. Loch Caruso
Late-Gestation Rat Myometrial Cells Express Multiple Isoforms of Phospholipase A2 That Mediate PCB 50-Induced Release of Arachidonic Acid with Coincident Prostaglandin Production
Toxicol. Sci.,
November 1, 2005;
88(1):
222 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Fisher, C. Dodia, S. I. Feinstein, and Y.-S. Ho
Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2
J. Lipid Res.,
June 1, 2005;
46(6):
1248 - 1256.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|